Combatting bacterial resistance in Europe
Antimicrobial resistance represents a growing threat to human and animal health worldwide and, consequently, there is an urgent need for new medicines to treat resistant infections. The COMBACTE project (Combatting Bacterial Resistance in Europe) boosts antibiotic drug development by pioneering new ways of designing and implementing efficient clinical trials for novel antibiotics. COMBACTE is part of the New Drugs for Bad Bugs (ND4BB) initiative, a large European programme to tackle antimicrobial resistance.